4.7 Article

Simple and effective bacterial-based intratumoral cancer immunotherapy

Related references

Note: Only part of the references are listed.
Review Cell Biology

How does the gut microbiome influence immune checkpoint blockade therapy?

Andrew A. Almonte et al.

Summary: Studies have shown that the gut microbiome directly impacts the outcome of cancer treatment, potentially serving as a key factor in improving the efficacy of immune checkpoint blockade therapy. However, many questions remain unanswered, including how bacteria function and how to utilize this information to influence treatment outcomes.

IMMUNOLOGY AND CELL BIOLOGY (2021)

Article Multidisciplinary Sciences

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

Erez N. Baruch et al.

Summary: This study conducted a phase 1 clinical trial and found that FMT treatment in patients with anti-PD-1-refractory metastatic melanoma, along with reinduction of anti-PD-1 immunotherapy, resulted in clinical responses in some patients. This suggests that modulating the gut microbiota could be a promising approach in cancer treatment.

SCIENCE (2021)

Article Multidisciplinary Sciences

Identification of bacteria-derived HLA-bound peptides in melanoma

Shelly Kalaora et al.

Summary: The study found that peptides derived from intracellular bacteria can be presented by tumor cells, eliciting an immune response and shedding light on how bacteria influence immune activation and therapy responses.

NATURE (2021)

Article Multidisciplinary Sciences

The human tumor microbiome is composed of tumor type-specific intracellular bacteria

Deborah Nejman et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

Bertrand Routy et al.

SCIENCE (2018)

Article Cell Biology

Eradication of spontaneous malignancy by local immunotherapy

Idit Sagiv-Barfi et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Review Gastroenterology & Hepatology

Enterocolitis due to immune checkpoint inhibitors: a systematic review

Emilie Soularue et al.

Review Immunology

Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica

Marco Antonio Hernandez-Luna et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2018)

Review Oncology

Tumour-targeting bacteria engineered to fight cancer

Shibin Zhou et al.

NATURE REVIEWS CANCER (2018)

Correction Oncology

Oncolytic viruses as engineering platforms for combination immunotherapy (vol 18, pg 419, 2018)

Kwame Twumasi-Boateng et al.

NATURE REVIEWS CANCER (2018)

Review Oncology

Canine cancer immunotherapy studies: linking mouse and human

Jiwon S. Park et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)

Article Biochemical Research Methods

Repeated fine-needle aspiration of solid tumours in mice allows the identification of multiple infiltrating immune cell types

Christina S. E. Carroll et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2015)

Article Multidisciplinary Sciences

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Marie Vetizou et al.

SCIENCE (2015)

Review Urology & Nephrology

The mechanism of action of BCG therapy for bladder cancer-a current perspective

Gil Redelman-Sidi et al.

NATURE REVIEWS UROLOGY (2014)

Article Cell Biology

Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses

Nicholas J. Roberts et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Article Multidisciplinary Sciences

The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

Sophie Viaud et al.

SCIENCE (2013)

Article Genetics & Heredity

Complex Inheritance of Melanoma and Pigmentation of Coat and Skin in Grey Horses

Ino Curik et al.

PLOS GENETICS (2013)

Article Cell Biology

A proposal for a simple and inexpensive therapeutic cancer vaccine

Aude M. Fahrer

IMMUNOLOGY AND CELL BIOLOGY (2012)

Article Multidisciplinary Sciences

Towards the Human Colorectal Cancer Microbiome

Julian R. Marchesi et al.

PLOS ONE (2011)

Article Genetics & Heredity

A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse

Gerli Rosengren Pielberg et al.

NATURE GENETICS (2008)

Review Oncology

Science and society - Translation of new cancer treatments from pet dogs to humans

Melissa Paoloni et al.

NATURE REVIEWS CANCER (2008)